We have investigated the mechanism by which high concentrations of glucose inhibit insulin stimulation of glycogen synthase. In NIH-3T3-L1 adipocytes cultured in low glucose (2.5 mM,
INTRODUCTION
glycosyltransferase (or O-glycosyl transferase, OGT) which glycosylates nuclear and cytosolic proteins with a single N-acetylglucosamine moiety on serine and threonine residues (O-GlcNAc) (18, 19) . This recently described protein modification is in many ways analogous to phosphorylation; it is dynamic and has been shown to occur exclusively on phosphoproteins.
Additionally, it has been shown to often have a reciprocal relationship with the degree of phosphorylation of a protein (20, 21) . Recent studies have suggested possible links between the O-GlcNAc modification on proteins and the pathogenesis of diabetes and insulin resistance. For example, insulin resistance of eNOS stimulation results when the Akt phosphorylation site of eNOS is modified by O-GlcNAc (22) . Transgenic over expression of OGT in skeletal muscle and fat results in the development of insulin resistance in mice, mimicking the effects of increased hexosamine flux (23) .
We have previously demonstrated that treatment of fibroblasts with high concentrations of glucose or glucosamine results in decreased basal activity of glycogen synthase and decreased stimulation by insulin (24) (25) (26) . To explore whether these effects might be due to direct 7 mM glucose and 10% fetal calf serum for 5 to 10 days, with the medium being changed every 3 days. Cells were passaged every 3 days with care taken to ensure that confluence was not reached before passaging (28, 29) . Experimental protocols were then begun. The differentiated adipocytes were placed in DMEM containing 1% fetal calf serum and either 2.5 mM glucose (low glucose, LG), 20 mM glucose (high glucose, HG), or 2.5 mM glucose plus 10 mM glucosamine (glucosamine, GlcN) for 24 h and again 30 min prior to harvesting. For insulintreated dishes, insulin (10 nM) was added 30 minutes prior to harvesting. The cells were harvested by placing on ice, washing twice with ice cold KRBH (25 mM HEPES pH 7.4, 150 mM sodium chloride, 4.4 mM potassium chloride, 1.2 mM sodium phosphate pH 7.4, 1 mM magnesium chloride and 1.9 mM calcium chloride) and then extracted with 0.75 ml of extraction buffer (50 mM HEPES pH 7.4, 100 mM sodium chloride, 5% glycerol (v/v), 1 mM 2-acetamido-1-amino-1,2-dideoxy-glucopyranoside, 40 mM sodium fluoride, and protease inhibitors). If β-D-hexosaminidase or phosphatase digests were to be conducted, then the extraction buffer consisted of 25 mM HEPES pH 7.4, 100 mM sodium chloride, and 5% glycerol with protease inhibitors. The resulting extracts were sonicated with a Sonic Dismembrator F60 for 15 s at setting 4 (Fischer Scientific, Pittsburgh, PA) and centrifuged at 20 000g for 2 minutes at 4˚C.
The supernatant was aspirated and aliquots immediately frozen in liquid nitrogen.
Glycogen Synthase Assay. The assay for glycogen synthase was based on that published by Thomas et al. (30) . Extracts from differentiated adipocytes (7.5 µg protein) were mixed in a volume of 100 µl with 10.0 µmol HEPES pH 7.4, 0.5 µmol EDTA pH 7.4, 0.8 mg glycogen (type-III from rabbit liver), 0.2 µmol UDP-glucose, 10 µl glycerol, 0 -0.3 µmol G6P and 0.4 µCi UDP- [6- 3 H]glucose and incubated for 45 min at 37˚C. The G6P concentrations used (0 -3 mM) reflect the physiological range in vivo (31) . The incubation was terminated by application to Whatman qualitative filter paper number 3 (Maidstone, England) and immersion in 60% (v/v) ethanol. After 5 washes in 200 ml of 60% ethanol, the paper squares were washed once in acetone, dried and assayed for tritium. All assays were done in duplicate. The incorporation of tritium was found to be optimal at 37˚C and linear for 120 minutes. The resulting data were analyzed by the least-squares algorithm, for a single rectangular hyperbola, using SigmaPlot for Windows version 4.0 (SSPS Science, Chicago, IL). G6P-independent glycogen synthase activity (I-form) is defined as basal activity. The half-maximal activation value (A 0.5 ) was defined as the concentration of G6P to achieve 50% activation of the G6P dependent activity (D-form). P values for the A 0.5 value and basal activity were determined using the values from each separate experiment and conducting a T-Test on Microsoft Excel 98 (Microsoft Corporation). The total activity (I-form + D-form) was defined as the activity at maximal G6P (3 mM).
Western Blotting. Protein concentrations in adipocyte extracts were determined using the Bio- (Sigma P-7937) (34) . . When extracts were to be treated only with phosphatases, the treatments were done in the presence of 100 µM 2-acetamido-2-deoxy-castanospermine (CaspNAc).
Complete digestion had occurred by 15 minutes (data not shown). For digestion with
β-D-hexosaminidase the pH of the extract (100 µg protein in 25 µl) was adjusted to 5.5 by the addition of 25 µl hexosaminidase buffer (20 mM sodium citrate pH 4.5, 10% glycerol, 100 mM sodium chloride and protease inhibitors) with or without 2 Units of β-N-acetylglucosaminidase from jack beans (Sigma) in the same buffer. After the addition of 5 µl 1 mg/ml bovine serum albumin (Roche) and 5 µl 20 mg/ml glycogen, the preparation was incubated for 2 h at 30˚C.
The reaction was stopped by the addition of 20 µl 100 mM HEPES pH 8.8 and 1 µl of 100 mM CaspNAc (35) . When CaspNAc was added before hexosaminidase, no change in glycogen synthase was observed (data not shown). After subsequent phosphatase digestion, the glycogen synthase activation was measured by duplicate assays at 0 and 3 mM G6P.
RESULTS

Glycogen Synthase from Cells Cultured with High Glucose or Glucosamine Exhibits Insulin
Resistance and Reduced Sensitivity to Glucose-6-Phosphate. Differentiated NIH 3T3-L1 adipocytes were cultured for 24 hours with 2.5 mM glucose (low glucose), 20 mM glucose (high glucose) or 10 mM glucosamine plus 2.5 mM glucose (glucosamine). These treatments had a significant effect on the sensitivity of glycogen synthase to G6P. In cells cultured in low glucose, glycogen synthase was sensitive to G6P (A 0.5 =162 ± 15 µM) and became more sensitive when cells were treated with insulin (A 0.5 = 96 ± 10 µM, p < 0.05, Figure 1a and d).
Glycogen synthase from cells cultured in high glucose was less sensitive to G6P (A 0.5 = 558 ± 61 µM, p < 0.02) and insulin did not increase the sensitivity to G6P to same degree as was observed Legend).
Culture with high glucose or glucosamine also affected the G6P-independent, or basal activity of glycogen synthase. When adipocytes cultured with low glucose were treated with insulin the basal activity increased from 8.7 ± 1.0% to 18 ± 1% of total activity (p < 0.002). Both high glucose and glucosamine treatments resulted in lower basal synthase activities and less insulin stimulation. When cultured with high glucose, insulin treatment increased G6P-independent activity from 1.2 ± 0.1% to only 4.7 ± 0.7% (p < 0.005 and p < 0.001, with and without insulin, compared to low glucose). Cells cultured with glucosamine showed a change of basal activity from 3.0 ± 0.5% to 7.4 ± 1.8% with insulin stimulation (p = 0.075 and p < 0.005, with and without insulin, compared to low glucose).
Changes in Glycogen Synthase Activity Induced by Treatment in High Glucose or Glucosamine Do Not Correlate with the Phosphorylation State of the Enzyme.
Normally an increase in the A 0.5 value for G6P and concomitant decrease in basal activity of glycogen synthase would be associated with increased phosphorylation. We therefore examined the phosphorylation state of the enzyme, using a polyclonal antibody against a phosphopeptide of the GSK-3 recognition region of the enzyme (hGS 642 -662) ( Figure 2 ). Synthase from cells cultured with high glucose showed a slight increase in phosphorylation relative to low glucose treatment that was not statistically significant (39 ± 29%; p = 0.17). Paradoxically, cells cultured with glucosamine showed a decrease in phosphorylation to 61 ± 9% of the level seen in low glucose (p < 0.001), despite the high A 0.5 value for G6P and lower basal activity.
The phosphorylation of the enzyme was responsive to insulin ( Figure 2 ). Glycogen synthase from adipocytes cultured with low glucose showed a 70 ± 7% decrease in phosphorylation when treated with 10 nM insulin (p < 0.001). However, adipocytes treated with high glucose or glucosamine exhibited insulin resistance. In these cases, phosphorylation decreased by 44 ± 11% (p < 0.05) and 30 ± 13% (p = 0.10) after insulin treatment, less than that observed for cells in low glucose (p < 0.05).
High Glucose and Glucosamine Treatments Increase Global Levels of Protein Modification by
Terminal O-GlcNAc. The changes in glycogen synthase seen in cells cultured in high glucose or When extracts from low glucose cultures were digested with protein phosphatase 1 in vitro, basal activity of glycogen synthase increased to 54 ± 7% compared to 12 ± 2% in non-digested extracts (p < 0.001, Figure 5a ). When extracts from high glucose cultures were digested with phosphatase, the basal activity increased only to 13 ± 2%. Extracts from glucosamine cultured cells were also resistant to phosphatase treatment, with basal activity increasing to only 16 ± 2%.
Consistent with the change in basal activity, the A 0.5 concentration for G6P decreased with phosphatase digestion of the low glucose cultured extract, from 78 ± 12 µM to 13 ± 5 µM G6P (p < 0.025). The decrease in the A 0.5 value was less in the high glucose and glucosamine extracts (51 ± 6 µM G6P for high glucose and 37 ± 4 µM G6P for glucosamine treatment). The experiments above were performed in the presence of CaspNAc, an inhibitor of the endogenous O-GlcNAcase activity in the cell extracts.
We next determined if the resistance to activation of glycogen synthase by protein phosphatase 1 was due to modification by O-GlcNAc. Adipocyte extracts without added CaspNAc were predigested with β-D-N-acetylglucosaminidase before phosphatase digestion. With removal of O-GlcNAc, glycogen synthase could be normally activated (Figure 5b ). With combined hexosaminidase and phosphatase digestion, basal activity increased to 74 ± 3%, 77 ± 3% and 80 ± 0% of total activity for low glucose, high glucose and glucosamine cultured extracts respectively. A similar increase also occurred in samples from insulin-treated cells (data not shown). Digestion of the extracts with hexosaminidase alone produced smaller increases in basal activity to 7.3 ± 0.3%, 15 ± 0.0% and 11 ± 1%, respectively. To confirm that the phosphatase digestion was complete, a western blot of each digest condition was stained with the antiphosphoglycogen synthase antibody (Figure 5c ).
DISCUSSION
Acute regulation of net glycogen synthesis by carbohydrate occurs through multiple mechanisms, including substrate availability, hormone signaling and allosteric activation. In addition, chronic hyperglycemia leads to changes in glycogen synthase activity by mechanisms that remain poorly understood. Our data demonstrate that one mechanism affecting synthase activity is mediated by increases in hexosamine flux and subsequent O-glycosylation of the enzyme. A nutrient sensing and signaling role for the hexosamine biosynthetic pathway (HBP) was first demonstrated by Marshall, who showed that the HBP mediated the ability of high glucose to induce insulin resistance in cultured adipocytes (15) . Since then, studies in cultured cells and animals have verified that the HBP plays a major role in the regulation of metabolism and growth (16, 17, 24, 36, (39) (40) (41) (42) (43) (44) (45) (46) . The HBP has also been shown to be responsible for glucose regulation of several proteins including TGFα, steroid response element binding protein 1, TGFβ1, plasminogen activator inhibitor-1, leptin, NFκB and endothelial nitric oxide synthase (eNOS) (17, 22, (47) (48) (49) (50) (51) (52) (53) (54) (55) . Flux through the HBP is responsive not only to glucose but also to fatty acids and oxidative stress (56) (57) (58) .
UDP-GlcNAc, the terminal metabolite of the HBP, is a substrate for protein glycosylation, suggesting a possible mechanism for the regulatory effects of the hexosamine pathway.
Glycosylation of secreted or plasma membrane proteins is not responsive to glucose flux (59).
However, O-linked glycosylation of cytosolic proteins is substrate-limited and proportional to glucose flux, making feasible a nutrient sensing function for that pathway (59) (60) (61) (62) . OGT, which catalyzes the modification of cytosolic proteins by GlcNAc at serine and threonine residues, has a high K m value, allowing the production of UDP-GlcNAc to be reflected in levels of protein glycosylation (19, 60, 63) . 
